Generating a human induced pluripotent stem cell line (XACHi018-A) from a Timothy syndrome infant carrying heterozygous CACNA1C c.1216G>A > A (p.G406R) mutation

被引：0
|
作者：
Jiang, Congshan [1 ]
Huang, Wenjun [1 ]
Zhou, Yafei [1 ]
Wang, Jie [1 ]
Lei, Hong [1 ]
Niu, Youguo [3 ]
Zhou, Rui [1 ]
Zhang, Yanmin [1 ,2 ]
机构：
[1] Xian Jiaotong Univ Xian, Xian Childrens Hosp,Xian Key Lab Childrens Hlth &, Shaanxi Inst Pediat Dis,Key Lab Precis Med Pediat, Natl Reg Childrens Med Ctr Northwest,Affiliated Ch, 69 Xijuyuan Lane, Xian 710003, Peoples R China
[2] Xi An Jiao Tong Univ, Xian Childrens Hosp, Dept Cardiol, Affiliated Childrens Hosp, Xian, Peoples R China
[3] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England
来源：
STEM CELL RESEARCH | 2024年 / 80卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.scr.2024.103513
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Timothy syndrome, an extremely rare disease, is closely associated with a mutation in CACNA1C gene, which encodes the cardiac L-type voltage-gated calcium channel (Cav1.2). In this study, we generated a human induced pluripotent stem cell (iPSC) line from a Timothy syndrome infant carrying heterozygous CACNA1C mutation (transcript variant NM_000719.7c.1216G>A: p.G406R). The generated iPSC line showed typical stem cell morphology, positively expressed pluripotency and proliferation markers, normal karyotype, and trilineage differentiation potential. Therefore, this patient-specific iPSC can be of great significance in investigating the mechanisms underlying Timothy syndrome, and hence establishing effective intervention strategies.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489+1G > A mutation
    Zhou, Danni
    Sun, Yaxun
    Shen, Jiaxi
    Su, Jun
    Gong, Tingyu
    Jiang, Chenyang
    Liang, Ping
    STEM CELL RESEARCH, 2020, 48
  • [42] p Generation of a human induced pluripotent stem cell line (UQi001-A-1) edited with the CRISPR-Cas9 system to carry the heterozygous TARDBP c.1144G > A (p.A382T) missense mutation
    Tracey, Timothy J.
    Jiang, Leanne
    Gill, Melinder K.
    Ranie, Samara N.
    Ovchinnikov, Dmitry A.
    Wolvetang, Ernst J.
    Ngo, Shyuan T.
    STEM CELL RESEARCH, 2023, 70
  • [43] Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene
    Li, Rong
    Pradhan, Manisha
    Xu, Miao
    Baskfield, Amanda
    Farkhondeh, Atena
    Cheng, Yu-Shan
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Might, Matthew
    Rodems, Steven
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 34
  • [44] Establishment and characterization of ZJUCHi003: an induced pluripotent stem cell line from a patient with Temple–Baraitser/Zimmermann–Laband syndrome carrying KCNH1 c.1070G > A (p.R357Q) variant
    Die Chen
    Jimei Su
    Xueying Huang
    Hongyu Chen
    Tiejia Jiang
    Chunchun Zhi
    Zuolin Zhou
    Bing Zhang
    Lan Yu
    Xiaoling Jiang
    Human Cell, 2024, 37 : 832 - 839
  • [45] Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation
    Lavra, Luca
    Magi, Fiorenza
    Ulivieri, Alessandra
    Morgante, Alessandra
    Paulis, Marianna
    Sala, Luca
    Pedrazzini, Matteo
    Polisca, Patrizio
    Rocchetti, Marcella
    Calo, Leonardo
    Sciacchitano, Salvatore
    Salehi, Leila B.
    STEM CELL RESEARCH, 2021, 54
  • [46] An induced pluripotent stem cell line (CIMRi001-A) from a Vici syndrome donor with a homozygous recessive c.1007A>G (p.Q336R) mutation in the EPG5 gene
    Mitchell, Matthew W.
    Grandizio, Christine
    Turan, Nahid
    Requesens, Deborah V.
    STEM CELL RESEARCH, 2022, 63
  • [47] Generation of an integration-free induced pluripotent stem cell line, FJMUUHi002-A, from a Rett syndrome patient with a heterozygous mutation p. R133C in MeCP2
    Guo, Yu
    Li, Jiaqi
    Xie, Wenyi
    Huang, Huaping
    Li, Jin-Jing
    Lin, Wanhui
    Lu, Ying-Qian
    STEM CELL RESEARCH, 2024, 74
  • [48] Generation of an induced pluripotent stem cell line (SJTUGHi003-A) from a patient with Sorsby fundus dystrophy carrying c.484G>A mutation in TIMP3 gene
    Zhu, Xinyue
    Tang, Lu
    Zhang, Ting
    Bai, Xinyue
    Chen, Jieqiong
    Zhang, Lei
    Gong, Yuanyuan
    Jiang, Mei
    Sun, Xiaodong
    STEM CELL RESEARCH, 2024, 77
  • [49] Marfan syndrome human induced pluripotent stem cell line with a heterozygous FBN1 c. 4082GN>A mutation, ISMMSi002-B, for disease modeling
    Klein, Sandra
    Dvornik, Jill L.
    Yarrabothula, Akshitha R.
    Schaniel, Christoph
    STEM CELL RESEARCH, 2017, 23 : 73 - 76
  • [50] Human induced pluripotent stem cell line (ONHi001-A) generated from a patient with infantile neuroaxonal dystrophy having PLA2G6 c.517C > T (p.Q173X) and c.1634A > G (p.K545R) compound heterozygous mutations
    Fukusumi, Hayato
    Togo, Kazuyuki
    Beck, Goichi
    Shofuda, Tomoko
    Kanematsu, Daisuke
    Yamamoto, Atsuyo
    Sumida, Miho
    Baba, Kousuke
    Mochizuki, Hideki
    Kanemura, Yonehiro
    STEM CELL RESEARCH, 2023, 69
12345